Intrust Bank NA Has $417,000 Stake in Koninklijke Philips (NYSE:PHG)

Intrust Bank NA increased its position in Koninklijke Philips (NYSE:PHG) by 41.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,454 shares of the technology company’s stock after buying an additional 4,781 shares during the period. Intrust Bank NA’s holdings in Koninklijke Philips were worth $417,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wilmington Savings Fund Society FSB acquired a new position in shares of Koninklijke Philips during the 3rd quarter worth $54,000. Farther Finance Advisors LLC boosted its holdings in Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after purchasing an additional 582 shares in the last quarter. Whipplewood Advisors LLC acquired a new position in Koninklijke Philips during the fourth quarter worth $55,000. Millstone Evans Group LLC bought a new position in Koninklijke Philips during the fourth quarter valued at about $60,000. Finally, Allworth Financial LP lifted its position in shares of Koninklijke Philips by 24.9% in the fourth quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock worth $105,000 after buying an additional 797 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Performance

PHG opened at $25.65 on Monday. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59. The stock’s 50 day moving average price is $26.73 and its two-hundred day moving average price is $27.55. The firm has a market capitalization of $24.10 billion, a P/E ratio of -30.53, a price-to-earnings-growth ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a 12-month low of $19.10 and a 12-month high of $32.91.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The business had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.10 billion. On average, equities analysts forecast that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The business also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s payout ratio is -89.29%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on PHG shares. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, March 18th. UBS Group raised shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a research report on Thursday, February 20th. BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, March 8th. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.